Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
MENS	Jyong Biotech Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.67M	n/a	n/a	n/a	-$0.06
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85
MDCX	Medicus Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$47.28M	n/a	n/m	n/a	-$2.74
MCRB	Seres Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$5.70M	n/a	12.9%	n/a	$0.64
MBX	MBX Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$86.97M	n/a	-23.6%	n/a	-$2.38
MBRX	Moleculin Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$33.56M	n/a	-223.6%	n/a	n/a
MBIO	Mustang Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.92M	n/a	-20.2%	n/a	-$0.39
MANE	Veradermics, Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$70.00M	n/a	n/a	n/a	-$111.91
MAIA	MAIA Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.40M	n/a	-942.7%	n/a	-$0.70
LYEL	Lyell Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.0K	-$274.45M	n/m	-110.6%	-41.0%	-$16.06
LXRX	Lexicon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$49.80M	-$50.34M	-101.1%	-46.8%	60.2%	-$0.14
LTRN	Lantern Pharma Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.12M	n/a	-262.0%	n/a	-$1.57
LSTA	Lisata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.0K	-$16.59M	n/m	-111.7%	-83.0%	-$1.91
LRMR	Larimar Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$165.67M	n/a	-212.2%	n/a	n/a
LQDA	Liquidia Corp Manufacturing · Year ended 2025-12-31 · USD	$158.32M	-$68.92M	-43.5%	-154.0%	n/m	-$0.80
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
LNAI	Lunai Bioworks Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$178.01M	n/a	n/a	n/a	-$1.08
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
LITS	Lite Strategy, Inc. Manufacturing · Year ended 2025-06-30 · USD	$0	-$15.95M	n/a	-94.2%	-100.0%	-$2.39
LIFD	Lftd Partners Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.92M	-$24.86M	-67.3%	-196.8%	-1.1%	-$1.68
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
LGND	Ligand Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$268.09M	$124.45M	46.4%	12.2%	60.4%	$6.13
LFVN	Lifevantage Corp Manufacturing · Year ended 2026-06-30 · USD	$182.59M	$5.07M	2.8%	15.1%	-20.1%	$0.40
LFCR	Lifecore Biomedical, Inc. Manufacturing · Year ended 2025-05-25 · USD	$128.87M	-$38.72M	-30.0%	n/m	0.5%	-$1.27
LEXX	Lexaria Bioscience Corp. Manufacturing · Year ended 2025-08-31 · USD	$705.9K	-$11.90M	n/m	-398.1%	52.0%	-$0.66

Rows per page: 2550 100